Condition

Non Arteritic Anterior Ischemic Optic Neuropathy (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2/phase 3 (1)

Sponsor

Quark Pharmaceuticals (1)

Collaborator

Intervention

qpi-1007 injection - 1.5 mg (1)

qpi-1007 injection - 3.0 mg (1)

sham injection procedure (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

non arteritic anterior ischemic optic neuropathy

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non Arteritic Anterior Ischemic Optic Neuropathy Trial in Worldwide (QPI-1007 Injection - 1.5 mg, QPI-1007 Injection - 3.0 mg,

Terminated

Non Arteritic Anterior Ischemic Optic Neuropathy

QPI-1007 Injection - 1.5 mg
+2 more

Little Rock, Arkansas
+84 more

Jul 16, 2020